# Agios Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 26, 2023

- Company: [Agios Pharmaceuticals, Inc.](/companies/agio.md) (CIK 1439222)
- Form: DEF 14A
- Filed: 2023-04-26
- Accepted by EDGAR: Apr 26, 2023, 16:03 ET
- Period: not reported
- Accession: 0001193125-23-118490
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1439222/000119312523118490/d770901ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1439222/000119312523118490/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1439222/000119312523118490/d770901ddef14a.htm

Filed Apr 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-118490. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
